During the past decade, MBAL Serdika EOOD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MBAL Serdika EOOD" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MBAL Serdika EOOD" are "Cancer of Unknown Primary Site" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Gastric Cancer" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "MBAL Serdika EOOD" in a lesser frequency.

Most popular intervention types in "MBAL Serdika EOOD" are "Drug" (9 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (3 trials), "Bevacizumab" (3 trials), "Atezolizumab" (2 trials), "Cisplatin" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "MBAL Serdika EOOD" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MBAL Serdika EOOD". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in MBAL Serdika EOOD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MBAL Serdika EOOD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".